Tiempo de aparición de la bromosulftaleína en bilis: su valoración en el diagnóstico de las ictericias

Sotto Escobar, Arcadio; Moreno Luna, Antonio; Más Páez, Juan A.; Rizo, Yolanda; Cuevas, Marina.
Rev. cuba. med ; 12(4-5-6): 373-376, jul.-dic. 1973. tab
Artículo en Español | CUMED | ID: cum-26005

Documentos relacionados

  1. Pharmaceutical suspensions of ursodeoxycholic acid for pediatric patients: <i>in vitro</i> and <i>in vivo</i> studies.
  2. Ursodeoxycholic acid in pregnancy?
  3. Combination of submicroemulsion and phospholipid complex for novel delivery of ursodeoxycholic acid.
  4. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
  5. Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population.
  6. Clarification of Obeticholic Acid Dosing: Response to "Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation" by Quigley et al.
  7. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
  8. No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.
  9. [Characteristics of a new controlled release formulation of ursodesoxycholic acid].
  10. Absorption, distribution and excretion of GT31-104, a novel bile acid sequestrant, in rats and dogs after acute and subchronic administration.